• Parkinson’s Research

  Enrollment in Phase 2 Study of Parkinson’s Cognitive Treatment Paused

  Posted by Community Member on May 26, 2020 at 10:14 am

  

  The U.S. safety and tolerability trial will not enroll people with mild cognitive impairment due to Parkinson’s until safety amid COVID-19 is more assured. Click here to read the full story.

  Are you part of any research studies that have been delayed or paused due to COVID-19?

  Community Member replied 5 years, 11 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply